XVIVO Perfusion AB is a medical technology company that specializes in developing optimized solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation. With a strong focus on medical science, XVIVO collaborates with transplant teams to increase the survival rates of patients awaiting transplantation by providing innovative products and systems that improve the transplant process outcome and expand the pool of transplantable organs.
Founded in 1998, XVIVO is headquartered in Gothenburg, Sweden, and has offices and research sites on three continents. As the only medical technology company dedicated to extending the life of all major organs, XVIVO's solutions enable leading clinicians and researchers to push the boundaries of transplantation medicine, ultimately saving more lives around the world.
Generated from the website